3 research outputs found

    Synthesis of Stable Multifunctional Perfluorocarbon Nanoemulsions for Cancer Therapy and Imaging

    No full text
    Nanotechnology provides a promising platform for drug-delivery in medicine. Nanostructured materials can be designed with desired superparamagnetic or fluorescent properties in conjunction with biochemically functionalized moieties (i.e., antibodies, peptides, and small molecules) to actively bind to target sites. These multifunctional properties make them suitable agents for multimodal imaging, diagnosis, and therapy. Perfluorohexane nanoemulsions (PFH-NEs) are novel drug-delivery vehicles and contrast agents for ultrasound and photoacoustic imaging of cancer <i>in vivo</i>, offering higher spatial resolution and deeper penetration of tissue when compared to conventional optical techniques. Compared to other theranostic agents, our PFH-NEs are one of the smallest of their kind (<100 nm), exhibit minimal aggregation, long-term stability at physiological conditions, and provide a noninvasive cancer imaging and therapy alternative for patients. Here, we show, using high-resolution imaging and correlative techniques, that our PFH-NEs, when in tandem with silica-coated gold nanoparticles (scAuNPs), can be used as a drug-loaded therapeutic via endocytosis and as a multimodal imaging agent for photoacoustic, ultrasound, and fluorescence imaging of tumor growth

    Synthesis of Stable Multifunctional Perfluorocarbon Nanoemulsions for Cancer Therapy and Imaging

    No full text
    Nanotechnology provides a promising platform for drug-delivery in medicine. Nanostructured materials can be designed with desired superparamagnetic or fluorescent properties in conjunction with biochemically functionalized moieties (i.e., antibodies, peptides, and small molecules) to actively bind to target sites. These multifunctional properties make them suitable agents for multimodal imaging, diagnosis, and therapy. Perfluorohexane nanoemulsions (PFH-NEs) are novel drug-delivery vehicles and contrast agents for ultrasound and photoacoustic imaging of cancer <i>in vivo</i>, offering higher spatial resolution and deeper penetration of tissue when compared to conventional optical techniques. Compared to other theranostic agents, our PFH-NEs are one of the smallest of their kind (<100 nm), exhibit minimal aggregation, long-term stability at physiological conditions, and provide a noninvasive cancer imaging and therapy alternative for patients. Here, we show, using high-resolution imaging and correlative techniques, that our PFH-NEs, when in tandem with silica-coated gold nanoparticles (scAuNPs), can be used as a drug-loaded therapeutic via endocytosis and as a multimodal imaging agent for photoacoustic, ultrasound, and fluorescence imaging of tumor growth

    Single-Molecule Analysis of the Supramolecular Organization of the M<sub>2</sub> Muscarinic Receptor and the GĪ±<sub>i1</sub> Protein

    No full text
    G protein-coupled receptors constitute the largest family of transmembrane signaling proteins and the largest pool of drug targets, yet their mechanism of action remains obscure. That uncertainty relates to unresolved questions regarding the supramolecular nature of the signaling complex formed by receptor and G protein. We therefore have characterized the oligomeric status of eGFP-tagged M<sub>2</sub> muscarinic receptor (M<sub>2</sub>R) and G<sub>i1</sub> by single-particle photobleaching of immobilized complexes. The method was calibrated with multiplexed controls comprising 1ā€“4 copies of fused eGFP. The photobleaching patterns of eGFP-M<sub>2</sub>R were indicative of a tetramer and unaffected by muscarinic ligands; those of eGFP-G<sub>i1</sub> were indicative of a hexamer and unaffected by GTPĪ³S. A complex of M<sub>2</sub>R and G<sub>i1</sub> was tetrameric in both, and activation by a full agonist plus GTPĪ³S reduced the oligomeric size of G<sub>i1</sub> without affecting that of the receptor. A similar reduction was observed upon activation of eGFP-GĪ±<sub>i1</sub> by the receptor-mimic mastoparan plus GTPĪ³S, and constitutively active eGFP-GĪ±<sub>i1</sub> was predominantly dimeric. The oligomeric nature of G<sub>i1</sub> in live CHO cells was demonstrated by means of FoĢˆrster resonance energy transfer and dual-color fluorescence correlation spectroscopy in studies with eGFP- and mCherry-labeled GĪ±<sub>i1</sub>; stochastic FRET was ruled out by means of non-interacting pairs. These results suggest that the complex between M<sub>2</sub>R and holo-G<sub>i1</sub> is an octamer comprising four copies of each, and that activation is accompanied by a decrease in the oligomeric size of G<sub>i1</sub>. The structural feasibility of such a complex was demonstrated in molecular dynamics simulations
    corecore